On May 2, 2024, Maziar Mike Doustdar, Executive Vice President of Novo Nordisk A/S, sold a total of 55,291 shares at prices ranging from DKK 900.00 to DKK 912.15, totaling approximately DKK 48.3 million (around USD 7 million). This filing is a routine disclosure of insider trading as required by regulations.